Financials data is unavailable for this security.
View more
Year on year Genor Biopharma Holdings Ltd had revenues fall -100.00% from 15.93m to 0.00, though the company grew net income from a loss of 730.21m to a smaller loss of 674.36m.
| Gross margin | 97.59% |
|---|---|
| Net profit margin | -3,638.27% |
| Operating margin | -3,769.79% |
| Return on assets | -33.87% |
|---|---|
| Return on equity | -40.03% |
| Return on investment | -39.06% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Genor Biopharma Holdings Ltd fell by 423.22m. However, Cash Flow from Investing totalled 5.99m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 425.12m for operations while cash used for financing totalled 6.82m.
| Cash flow per share | -0.9893 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.23 |
|---|---|
| Tangible book value per share | 2.01 |
More ▼
Balance sheet in CNYView more
| Current ratio | 5.76 |
|---|---|
| Quick ratio | 5.73 |
| Total debt/total equity | 0.003 |
|---|---|
| Total debt/total capital | 0.003 |
More ▼
